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ABSTRACT
Extrachromosomal circular DNA (eccDNA) and ring
chromosomes are genetic alterations found in hu-
mans with genetic disorders. However, there is a lack
of genetic engineering tools to recapitulate and study
the biogenesis of eccDNAs. Here, we created a dual-
fluorescence biosensor cassette, which upon the de-
livery of pairs of CRISPR/Cas9 guide RNAs, CRISPR-
C, allows us to study the biogenesis of a specific fluo-
rophore expressing eccDNA in human cells. We show
that CRISPR-C can generate functional eccDNA, us-
ing the novel eccDNA biosensor system. We fur-
ther reveal that CRISPR-C also can generate eccD-
NAs from intergenic and genic loci in human embry-
onic kidney 293T cells and human mammary fibrob-
lasts. EccDNAs mainly forms by end-joining medi-
ated DNA-repair and we show that CRISPR-C is able
to generate endogenous eccDNAs in sizes from a
few hundred base pairs and ranging up to 207 kb.
Even a 47.4 megabase-sized ring chromosome 18
can be created by CRISPR-C. Our study creates a
new territory for CRISPR gene editing and highlights
CRISPR-C as a useful tool for studying the cellular
impact, persistence and function of eccDNAs.
INTRODUCTION
The Clustered Regularly Interspaced Short Palindromic
Repeats (CRISPR) and CRISPR-associated protein 9
(Cas9) is an adaptive immune system in bacteria and ar-
chaea that eliminate phages (1). Mediated by a small guide
RNA (gRNA), the endonuclease Cas9 is harnessed for gene
editing and has quickly become a highly attractive and pow-
erful tool in basic and applied research (2–4). The fidelity
and nuclease-precision of the CRISPR–Cas9 system insures
no or minimal off-target effects and facilitates fast, func-
tional gene studies of e.g. site-directed mutations in eukary-
otic cells. Moreover, CRISPR–Cas9 mediated gene knock-
outs can be created through a pair of gRNAs that triggers
dual double-stranded DNA breaks at essential exons, lead-
ing to DNA deletion and functional disruption of the gene
encoded protein (3,4) or the inactivation of porcine endoge-
nous retroviruses (5).
However, it is commonly thought that excised DNA after
dual restriction by CRISPR–Cas9 will degrade or dilute out
through cell proliferations, yet the fate of deleted chromo-
somal DNA is still unknown. Any nuclear double-stranded
DNA breakage will in principle be recognized by the DNA
repair machinery and two breaks on the same chromosome
could led tomistakes, either by end joining or by homology-
directed repair of the deleted linear DNA fragment, re-
sulting in circular DNA formation. DNA deletions and
DNA inversions have previously been shown to form after
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dual restriction by CRISPR–Cas9 (6,7) but it remains to
be resolved whether deleted DNA fragments also form ex-
trachromosomal circular DNA (eccDNA). Genome-scale
studies have recently shown that eccDNAs are common el-
ements in human cells (8,9) and malignant tumors often
carry oncogene amplifications on eccDNAs, known as dou-
ble minutes (10–13). Chromosome-derived eccDNAs ap-
pear to arise mostly at random, although certain eccDNA
types form more frequently (8,9,14). Despite mounting ev-
idence of eccDNA prevalence, a direct connection between
DNAdeletions and eccDNA formation has so far only been
found sporadically (8,12,15,16) and for fifty years, cancer
studies of double minutes (microscopically visible eccD-
NAs) has been prohibited by limited cell models and ec-
cDNA detection techniques, underlying the need for more
directed genetic tools to facilitate eccDNA analyses.
In this study, we first created an exogenous dual-
fluorescence biosensor cassette (ECC biosensor) for study-
ing the biogenesis of a fluorophore gene-encoded eccDNA
in human cells. We discovered that a targeted DNA dele-
tion in the ECC biosensor, by a pair of CRISPR/Cas9
gRNAs, can form green fluorescent protein expressing ec-
cDNA in human cells after end-to-end DNA ligation. This
technology of generating extrachromosomal circular DNA
by CRISPR was hereafter referred as CRISPR-C. Using
CRISPR-C, we further demonstrated generation of ec-
cDNA from intergenic and genic loci and confirmed forma-
tion of eccDNAs in human cells, in sizes from a few hundred
base pairs up to a 47.4 megabase-sized ring chromosome,
chr18.
MATERIALS AND METHODS
Oligonucleotides
All oligonucleotides are ordered fromMerckKGaA,Darm-
stadt, Germany. The sequences for all oligonucleotides used
can be found in Supplementary Table S1 and S2.
Cell culture
Tissue cultures of human embryonic kidney 239T
(HEK293T) cells and normal immortalized human fi-
broblasts (HMF, clone MJ2646, a gift from Dr Bin Liu,
Danish Cancer Society, Denmark) were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) (LONZA)
supplemented with 10% fetal bovine serum (FBS) (Gibco),
1% GlutaMAX (Gibco), and penicillin/streptomycin (100
units penicillin and 0.1 mg streptomycin/ml) in a 37◦C
incubator with 5% CO2 atmosphere and maximum humid-
ity. HEK293T and MJ2646 cells were passaged typically
every 2–3 days at 1:8 and 1:3 ratio, respectively, when
reaching approximately 90% confluence. This was done
by washing cells twice (equal volume as growth medium)
gently with phosphate buffered saline (PBS, 1×) without
calcium and magnesium, followed by cell detachment by
0.05% Trypsin-EDTA for 3–5 min at 37◦C.
Resource of plasmids
The following vectors were used: lentiCRISPRv2 (a gift
from Feng Zhang, Addgene plasmid # 52961) and pUC19
(gift from Joachim Messing, Addgene plasmid # 50005).
The pMAX-GFP (VDF-1012) was supplied by the Amaxa
nucleofection kit. The PiggyBac hybase plasmid is gen-
erously provided by Prof. Jacob Giehm Mikkelsen from
the Department of Biomedicine, Aarhus University (http://
www.giehmlab.dk). Alternatively, the PiggyBac transposase
expression vector can be purchased from SBI system Bio-
sciences (Cat. # PB210PA-1).
Generation of eccDNA biosensors
The ECC biosensor fragments were synthesized by Gene
Universal Inc. (229A Lake Dr Newark De 19702, USA)
and validated by Sanger sequencing. The ECC biosen-
sor fragments, which contains fluorophore gene mark-
ers of enhanced green fluorescent protein (EGFP) and
the monomeric derivative of DsRed fluorescent protein
(mCherry), were sub-cloned into a PiggyBac transposon
vector (from Prof. George M. Church’s group, http://
arep.med.harvard.edu) carrying the pac gene, encoding a
puromycin N-acetyl-transferase that confer resistance to
puromycin (see Supplementary Figures S1 and S2). The fi-
nal PiggyBac transposon-based ECC biosensor plasmids
(CAG-ECC and TRE-ECC) were verified by restriction en-
zyme digestion.
Generation of CRISPR/Cas9 gRNAs
All CRISPRgRNAswere designedwith the online software
tool CRISPOR v4.2. The gRNAs were selected selecting
based on (i)minimal off-targets, i.e. off-targets that typically
requires more than three mismatches for perfect annealing
elsewhere; (ii) predicted activity over 30% provided by the
CRISPOR web tool; (iii) avoid strong secondary structure
of the guide sequences and (iv) absent of poly-thymine (max
3) and the BsmBI restriction site in the guide. All CRISPR
gRNA oligos with the corresponding overhangs used for
Golden Gate Assembly were ordered from Merck KGaA,
Darmstadt, Germany (Supplementary Table S1).
To generate CRISPR gRNA expression vector, we used
a previous optimized protocol. Briefly, for each gRNA, two
complementary guide oligonucleotides (100 pmol each) in
1× NEB buffer 2 (in a total volume of 20 l) were first
denatured at 95◦C for 5 min, using a heating block, fol-
lowed by slow annealing by turning off the heating block.
For Golden Gate Assembly, the following reaction mix
was prepared: 1 l of the above annealed oligonucleotides,
100 ng of the lentiCRISPRv2 plasmid, 1 l FastDigest
BsmBI restriction enzyme (Thermo Fisher Scientific), 1
l T4 Fast ligase (Thermo Scientific), and 2 l T4 lig-
ase buffer in a total volume of 20 l. Golden Gate As-
sembly was performed in a thermal cycler using the fol-
lowing program: Ten cycles of 37◦C for 5 min and 22◦C
for 10 min; one cycle of 37◦C for 30 min; and one cy-
cle of 75◦C for 15 min. The ligation product was stored
at 4◦C or used directly (2 l ligation product) to trans-
form competent Escherichia coli cells. Using this protocol,
we have experienced that over 95% of the bacterial clones
are positive by PCR screening using a U6 forward primer
(5′-GAGGGCCTATTTCCCATGATTC-3′) and the anti-
sense guide oligonucleotide (template strand of the gRNA
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/46/22/e131/5078801 by R
oyal Library C
openhagen U
niversity user on 15 January 2019
PAGE 3 OF 13 Nucleic Acids Research, 2018, Vol. 46, No. 22 e131
spacer). Sanger sequencing validated all gRNAvectors used
in this study.
Cell transfection
All transfections in this study were conducted with the X-
tremeGENE 9 transfection reagent (Roche) in 24-well plate,
if not stated elsewhere. Briefly, 60,000 cells, countedwith nu-
cleocounter NC-100 (Chemometec), were typically seeded
into a 24-well plate one day before transfection. For each
transfection, a total of 250 ng plasmid DNA and 0.75 l
X-tremeGENE 9 transfection reagent (1:3 ratio of g to-
tal DNA relative to transfection reagent), were mixed in 50
l OptiMEM (Gibco) and incubated at room temperature
for 15 min. The transfection mixture was homogeneously
added to the cells. Unless stated elsewhere, for transfec-
tion of pairs of CRISPR plasmid, equal amount of each
CRISPRplasmidwas used. As transfection control, pUC19
orGFP plasmidwas used for control groups. For evaluation
of endogenous eccDNA formation by CRISPR pairs, 1.5×
106 HEK293T cells or 2.2 × 106 HMF cells were seeded in
10-cm cell culture dish and transfected next day at ∼50%
cell confluence.
Generation of ECC biosensor stable clones
Stable ECC biosensor clones were generated by transfec-
tion of 60,000 HEK293T cells with 200 ng ECC biosen-
sor plasmid and 50 ng PiggyBac hybase plasmid using
X-tremeGENE 9. Twenty four hours post transfection,
transfected cells were cultured in complete medium supple-
mented with puromycin (1 g/ml). One-week after trans-
fection, the puromycin resistant cells were trypsinized, sin-
gle cell was manually picked under a stereomicroscope and
cultured in 96-well until 70–80% confluence. Single clones
normally evolve after 14 days in culture. The stable clones
were further expanded and the copy number of the inte-
grated ECC biosensor was assessed by Southern blot, prob-
ing forEGFP, using theECCbiosensor plasmid as reference
in 1, 5 and 10 copies/genome.
Fluorescence-activated cell sorting (FACS)
Cells, dissociated with 100 l trypsin-EDTA, were sus-
pended in 100l 5%FBS–PBS and transferred to a 96 deep-
well plate on ice. Cells were spun down∼800× g (2000 rpm)
for 5 min and the supernatant was removed by gently in-
verting the plate. For fixation, 200 l 4% paraformaldehyde
was added to the cells and mixed gently by pipetting. After
fixing for 15 min at room temperature, the fixed cells were
washed twice with 5% FBS–PBS. Lastly, cell pellets were
re-suspended in 500 l PBS and cells were kept at 4◦C un-
til FACS analysis. FACS was performed using a BD LSR-
Fortessa (supported by the FACS CORE facility, Depart-
ment of Biomedicine, Aarhus University) with at least 30
000 events collected for each sample. Data were analyzed
using Flowjo software.
Time-course analysis of ECC biosensor
The CAG-ECC (clone #1–9) and TRE-ECC (clone #1–15)
were transfected with Cr1 and Cr2. 72 hours after transfec-
tion (defined as passage 1), the transfected cells were dis-
sociated with 100 l trypsin-EDTA (37◦C for 5 min) and
re-suspended in 200 l 5% FBS-PBS medium. One-third of
the cells were analyzed by FACS, one-third of the cells were
used for PCR analysis, and the remaining one-third of the
cells were passaged to a new 24-well plate. The cells were
passaged every second day at a one-third ratio until passage
6.
EccDNA purification in human cells
Cells were harvested typically at 48 h after transfection
or harvested from a fraction of the transfected cells in
time-course experiments at various passages. Suspended,
trypsinized cells were pelleted at 425 x g (2000 rpm), 5 min.
The supernatant was removed and cells were lysed for ec-
cDNA analysis (see the following optimization method);
either by genotyping, using outward PCR and Sanger se-
quencing, or by Southern blot.
Optimization of endogenous eccDNA purification
To assess the methods for endogenous eccDNA purifica-
tion, three different protocols were tested before outward
PCR: (i) genomic DNA column purification; (ii) cell lysate;
(iii) plasmid DNA column purification. For each of the
three methods, cells were counted and fractionated in three
different concentrations: 105 cells, 104 cells and 102 cells.
Then, to each cell sample was spiked in 105 copies of pUC19
plasmid as internal control and protocols (i); (ii) or (iii) were
executed.
Genomic DNA column purification. Genomic DNA was
purified according to protocol (#056-60, A&A Biotechnol-
ogy). In brief, cells were lysed by protease for 30min at 55◦C,
the RNA was removed by RNase A/T1 mix (2 g/sample,
Thermo) and genomic DNA was washed and purified by
gravity flow on an ion exchange membrane (AX tissue), fol-
lowed byDNA precipitating at 14,000 x g for 30 min at 2◦C,
70% ethanol wash and finally dissolving the DNA pellet in
40 l Tris–Cl 10 mM, pH 8.0. Of the total 40 l DNA solu-
tion, 32 l was transferred for linear DNA removal, saving
the remaining 8 l at −20◦C until PCR analysis.
Cell lysate. Cells were suspended in 0.2 ml lysis buffer
(KCl 50 mM, MgCl2 1.5 mM, 0.5% NP40 and 0.5% Tween
20, 10 mMTris pH 8.5) and incubated with 10l proteinase
K (19.1mg/ml, Thermo) for 2.5 h at 55◦C. ProteinaseKwas
heat-inactivated at 95◦C for 10 min, cooled down at room
temperature for 15 min, and 32 l DNA solution was trans-
ferred for linear DNA removal, storing the rest of the cell
lysate at –20◦C until PCR analysis.
Plasmid DNA column purification. Plasmid DNA from
cells was purified according to protocol (#010-50, A&A
Biotechnology) after completed cell lysis in 0.6 ml L1
suspension buffer with 30 l proteinase K (19.1 mg/ml,
Thermo) for 6 h at 55◦C, and removal of RNA by RNase
A/T1 mix (2 g/sample, Thermo) at room temperature for
10 min. Plasmid DNA was washed and purified by gravity
flow on an ion exchange membrane (Plasmid 10 AX), fol-
lowed by DNA precipitating at 14 000 x g for 30 min at 2◦C,
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70% ethanol wash and finally dissolving the DNA pellet in
40 l Tris–Cl 10 mM, pH 8.0. Of the total 40 l DNA solu-
tion, 32 l was continued for linear DNA removal, saving
the remaining DNA at –20◦C until PCR analysis.
Removal of linear DNA
A maximum of 4–5 g total DNA (most cases < 2 g)
was digested with four fast digest units (Thermo Scien-
tific), using an endonuclease that did not cleave investigated
eccDNA, e.g. for most experiments XbaI (endogenous ec-
cDNA) or EcoRI (ECC biosensor) was used. Endonuclease
digestion was completed after 1 hour in a 40 l volume at
37◦C, followed by heat-inactivation, according to enzyme
protocol (e.g. 65◦C, 20 min). To the total 40 l endonucle-
ase digested DNA was added a 35 l Plasmid-Safe DNase
mixture (Epicentre, Illumina), containing 1.5 l Plasmid-
Safe DNase (15 units), 3 l ATP (25 mM), 7.5 l 10×
DNase reaction buffer and 23 l H2O. Samples were incu-
bated in a heating block at 37◦C for 16 h. Next day, linear
DNAdigestionwas continued by adding 5l fresh Plasmid-
Safe DNase mixture every two hours, consisting of 1.5 l
Plasmid-Safe DNase (15 units), 3 l ATP (25 mM ATP)
and 0.5 l 10× DNase reaction buffer and when reaching
90 units and ∼24 h digestion, DNase was heat-inactivated
at 70◦C for 30 min (see Supplementary Figures S13 and
S14). In case of the cell lysate protocol, the quick proto-
col included max 4 g DNA, endonuclease digestion of a
40 l cell lysate volume, conducted directly after cell lysis in
1× fast digest buffer at 37◦C for 16 h, in combination with
10 units Plasmid-Safe DNase and 2 l ATP (25 mM). Af-
ter heat-inactivation of the endonuclease, the Plasmid-Safe
DNase treatment was continued for additional 24–48 h (de-
pendent on DNA input), adding fresh Plasmid-Safe DNase
mixture step-wise and reaching up to 100 units/sample.
Polymerase chain reaction (PCR)
All PCR reactions were performed with the high-fidelity
platinum Pfx polymerase in the presence of 2× enhancer
solution (#11708013, Thermo). All PCR primers were or-
dered from fromMerckKGaA,Darmstadt,Germany (Sup-
plementary Table S2).
Southern blot analysis
Southern blot was performed using an optimized method
from our group. In brief, a total 15–25 g genomic DNA
was digested with EcoRI restriction enzyme overnight. The
enzyme digested DNA was separated on 1% agarose gel
for 16 h at 30 V. The DNA was transferred on to a mem-
brane by vacuum blotting. PCR primers for generating
the probe: 5′-ATTCACCGTCTCATCCAGCGAGGGC
GATGCCACCTAC-3′ and 5′-TAAGTCGGTCTCATC
AGTGGTTGTCGGGCAGCAGCAC-3′ (500 bp EGFP
probe). Probe labelling was performed using the Prime-It
II Random Primer Labeling Kit according to the manu-
facturer’s instructions. Pre-hybridization and hybridization
steps were carried out at 42◦C. Excess probe was washed
from the membrane with SSC buffer, and the hybridization
pattern was visualized on X-ray film by autoradiography. A
detailed protocol with step-by-step guidance can be found
at our group page: www.dream.au.dk.
Karyotyping
Cells were incubated with Chromosome Resolution Addi-
tive, diluted 1:10 000, and 500 ng/ml cholcemide for 2.5 h
at 37◦C. The culture was harvested by incubating with Try-
pLE for 10–20 min at 37◦C. Cells were collected by cen-
trifugation and the pellet was re-suspended in 0.4% KCl,
gently vortexed and subsequently incubated for 30 min at
37◦C. After re-centrifugation, the pellet was re-suspended
by adding fixative drop-wise up to 2 ml using 1 volume
acidic acid and 3 volume methanol. After 20 min fixation
at room temperature, cells were spun down and the fixa-
tion step was repeated twice. Chromosome spreads were
prepared by dripping the cell-suspension onto wet glass
slides in a humid atmosphere at 37◦C. The slide glasses were
stained, using quinacrine andmounted in antifade solution.
Fluorescent in situ hybridization (FISH) of telomere and
whole chromosome 18 painting
Slides were made with each of the cells suspensions pre-
pared for Karyotyping. Hybridization with PNA-telomere
probe in red was performed, followed by DAPI as coun-
terstain. Automated scanning of the slides was applied
to identify and locate metaphases, and image identified
metaphases were captured using the automated scan-
ning software. The telomere probe was stripped and re-
hybridization with whole chromosome 18 probes in green
followed by DAPI as counterstain. Relocation of previ-
ously captured metaphases followed by another capture of
painted metaphases was carried out. For wildtype parental
cells, we analyzed 65 metaphases. For CRISPR transfected
cells, we analyzed 113 metaphases. A more detailed FISH
protocol can be acquired from the authors.
Sanger sequencing
All Sanger sequencing in this study were conducted us-
ing the Mix2Seq Kit in Eurofins Genomics (Munich, Ger-
many). Sanger sequencing results were analyzed with Snap-
Gene Viewer or four peaks software.
Deep sequencing
Purified PCR products were mixed with End Repair Mix
(BGI Tech.), incubated at 20◦C for 30 min, then purified
with QIAquick PCR purification kit (Cat No./ID: 28104).
Purified PCR products were mixed with an A-Tailing reac-
tion (BGI Tech.), incubated at 37◦C for 30 min and puri-
fied with QIAquick PCR purification kit. PCR-free adap-
tor ligation was carried out by mixing the above 3′ adeny-
late DNA, PCR Free index adapters (BGI Tech.), T4 DNA
Ligase and buffer. The reaction was incubated at 16◦C for
16 h and purified with QIAquick PCR purification kit. The
ligated PCR products were purified by gel-electrophoresis
(2% agarose) and the QIAquick Gel Extraction Kit (Qia-
gen). The molecular length of the final sequencing library
was determined with Agilent 2100 bioanalyzer (Agilent
DNA 1000 Reagents) and sequenced with HiSeq2500 Sys-
tem (HiSeq SBS Kit V4, Illumina).
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Analysis of amplicon sequencing results
The theoretical circular sequences of
[dsCRPcircle 1q23.2:0.57 kb] and [TRIM28circle exon 1-2] were
generated based on human hg38. Clean reads were aligned
against the theoretical reference using the BWA-mem algo-
rithm. Duplicate removing was not suitable for amplicon
sequencing and thus omitted. Reads across the theoretical
end joining site (junction) were used for indel-calling.
Soft-clip reads were omitted.
Statistics
Analysis of correlation was conducted with Pearson rank
test.
RESULTS
Generation of an ECC biosensor and circular DNA induction
by CRISPR-C
To enable real-time monitoring of eccDNA biogenesis
in cells, we designed and synthesized a dual-fluorescence
biosensor cassette (ECC) with constitutive gene-expression:
CAG-ECC (Supplementary Figure S1) as well as a tetra-
cycline inducible biosensor: TRE-ECC (Figure 1 and Sup-
plementary Figure S2). The principle for each designed
ECC-cassette was to mark the outcome after DNA re-
pair of two introduced site-directed double-strand DNA
breaks in cultured human cells, using two CRISPR gR-
NAs (Cr1 + Cr2) (Figure 1A and Supplementary Figure
S3). A genomic DNA deletion, of the sequence encoding
enhanced green fluorescent protein (ΔEGFP), would lead
to functionalmCherry expression after end-joining with the
mCherry promoter (pCAG or pTRE). Likewise, EGFP ex-
pression was expected tomark circularization of the deleted
DNA fragment, leading to an [EGFPcircle]. Alternatively, an
inversion could also lead to expression of both EGFP and
mCherry but under a different expression scheme (Figure
1A and Supplementary Figure S3).
To experimentally test the ECC biosensor on a plasmid,
we transiently transfected human embryonic kidney 293T
cells (HEK293T) with CAG-ECC and Cr1+Cr2, along
with serial control transfections (Supplementary Figures
S4 and S5). As expected, only cells transfected with CAG-
ECC and Cr1+Cr2 expressed both EGFP and mCherry.
However, as transient transfection of the CAG-ECC vec-
tor could not distinguish eccDNA from inversion events
(Supplementary Figure S3) we also tested the inducible
TRE-ECC in HEK293T. Here the majority of the cells,
in absence of tetracycline, were EGFP positive, indicat-
ing [EGFPcircles], while substantially less cells were mCherry
positive (Figure 1B–D, Supplementary Figures S6 and S7).
Addition of tetracycline to cells enhanced both EGFP and
mCherry expression, supporting formation of [EGFPcircles]
as well as EGFP deletion (ΔEGFP) and EGFP inversions
(EGFPinv) when targeted by CRISPR pairs, hereafter re-
ferred as CRISPR-C.
Transient transfection is known to overload cells with
many copies of plasmids. To overcome plasmid overload-
ing and to distinguish inversions from eccDNAs, we es-
tablished stable HEK293T biosensor reporter cells by the
PiggyBac transposon system, which recognizes transposon-
specific inverted terminal repeat sequences (ITRs) of the
transposon vector and efficiently integrates ITRs and the
ITR-flanked genes into TTAA chromosomal sites. Nine sta-
ble CAG-ECC clones and fifteen stable TRE-ECC clones
were established. Each clone carried from one up to thir-
teen copies of the biosensor cassette, assessed by Southern
blotting (Figure 1E–G, Supplementary Figures S8 and S9).
Fluorescence-activated cell sorting (FACS) analysis of all
individual cell clones, induced by CRISPR-C (Cr1+Cr2),
revealed correlation between the ECC biosensor copy num-
ber per cell and themedian levels of EGFP+/mCherry+ co-
colored cells (R = [0.79 to 0.93], Pearson rank test, Supple-
mentary Figure S10). It further supported formation of flu-
orophore transcripts from eccDNA after CRISPR-C (Fig-
ure 1H, Supplementary Figures S8 and S9). Topological
confirmation of the 1.9 kb-sized [EGFPcircle], along with
ΔEGFP and EGFPinv, was obtained by Sanger sequencing
of PCR products and [EGFPcircles] were further confirmed
by Southern blot analysis for both the TRE- and the CAG-
ECC isolated clones (Figure 1I–J and Figure S11).
CRISPR-C can generate endogenous genic and intergenic ec-
cDNAs in human cells
Endogenous eccDNAhas previously been found in both tu-
mor and normal cells (8,10). We next investigated whether
CRISPR-C also could generate eccDNAs in human em-
bryonic kidney cells (HEK293T) and immortalized hu-
man mammary fibroblasts (HMF). EccDNAs are com-
monly derived from intergenic regions and often con-
sist of repeated sequences (8,17). Thus, we designed two
CRISPR gRNAs (Cr3+Cr4) targeting a site on chromo-
some 1 (chr1:159 708 525–159 709 943), which is located
2 kb downstream of the C-reactive protein encoding gene,
CRP, and contains a SINE (AluYk4) element (Figure 2A).
We first estimated the deletion efficiency to ∼50–70% af-
ter CRISPR-C (Cr3+Cr4) in HEK293T cells (Figure 2B
and C). We confirmed CRISPR inversion events in these
cells by PCR and Sanger sequencing (Figure 2D). Finally,
and as anticipated, CRISPR-C led to circularization of
the deleted DNA, resulting in formation of the 0.57 kb-
sized [dsCRPcircle 1q23.2:0.57 kb] (Figure 2E) validated by out-
ward PCR and Sanger sequencing. CRP circularization by
CRISPR-C was further validated by rolling circle ampli-
fication (data not shown). Since HEK293T cells are poly-
ploidy and a CRISPR duplication event potentially could
give a false-positive PCR signal for eccDNA (Supplemen-
tary Figure S12), we tested and validated three protocols
(genomic DNA preparation, cell lysate, and plasmid prepa-
ration) for eccDNA purification and exonuclease treat-
ment, in order to remove all linear/chromosomal DNA
(Supplementary Figure S13). We found that cost-effective
and conventional cell lysate protocol allowed us to detect
the [dsCRPcircle 1q23.2:0.57 kb] in 10∧5 cells, using outward di-
recting oligos PCR and Sanger sequencing. Controls con-
firmed complete removal of linear DNA but not plasmid
DNA (Supplementary Figure S13). The eccDNA purifica-
tion protocols were repeated inHMFcells, reaching compa-
rable results and conclusions (Supplementary Figure S14).
Thus, the cell lysate method (∼105 cells and exonuclease
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Figure 1. A dual-fluorescence eccDNA biosensor system and CRISPR-C for studying eccDNA biogenesis in human cells. (A) Model of TRE-ECC biosen-
sor after two double-stranded breaks by CRISPR-C (Cr1 and Cr2), leading to [EGFPcircle] and EGFP or EGFP inversion. (B) Scheme of TRE-ECC
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treatment) was hereafter used for all proceeding experi-
ments. Taken together, we found that CRISPR-C can gen-
erate intergenic eccDNA, both in immortalised human fi-
broblasts and in human cancer-like cells (HEK293T).
Next, we tested induction of DNA circularization by
CRISPR-C at two different genic loci (urokinase, UPA;
and tripartite motif containing 28, TRIM28) as endoge-
nous eccDNAs also are reported to derive from genic
sequences (8,10,13,18,19). In line with findings of the
[dsCRPcircle 1q23.2:0.57 kb], CRISPR-C led to generation of a
[UPAcircle exon 4] and a [TRIM28circle exon 1-2] both in HMF
as well as in HEK293T cells and their structures were
confirmed by Sanger sequencing of outward PCR prod-
ucts (Figure 2F-I and Supplementary Figures S15 and
S16). Hence, endogenous eccDNA formation by CRISPR-
C seems to be a general outcome in cells, since it is cell-line
independent and eccDNAs are formed both at genic loci
and at intergenic regions.
CRISPR-C eccDNA mainly forms by end-joining
Sanger sequencing of the circular junctions of
[EGFPcircle], [dsCRPcircle 1q23.2:0.57 kb], [UPAcircle exon 4]
and [TRIM28circle exon 1-2] gave evidence of end-joining
events. This data support previous notions that the major
DNA-repair pathway that appears to mediate eccDNA
formation in mammalian cells is non-homologous end
joining (NHEJ) (17,18). To better understand the indel
events, we further sequenced the DNA across the junction
of the [dsCRPcircle 1q23.2:0.57 kb] and the [TRIM28circle exon 1-2]
by next-generation sequencing. For CRISPR-C introduced
dsCRP eccDNA, we observed 68.8% and 77.6% blunt end-
joining (BEJ) in HEK293T and HMF cells, respectively
while the remaining 31.2% and 22.4% had a variable indel
size up to maximum 17 bp (Figure 2J and K). Similarly,
the majority of [TRIM28circle exon 1-2] indels was less than
4 bp (79%) (Supplementary Figure S16). Though, for
[TRIM28circle exon 1-2], we only observed 6.8% formed by
BEJ while a majority (61%) had either one nucleotide
insertion (43.3%) or deletion (13.2%) (Supplementary
Figure S17). Such an indel distribution has previously
been reported after CRISPR-editing (19,20). In sum, our
results suggest that the majority of eccDNAs generated by
CRISPR-C is formed by an end-joining mediated DNA
repair pathway.
The stability of CRISPR-C generated [EGFPcircles] in human
cells
To evaluate the stability of de novo generated eccDNA by
CRISPR-C, succeeding experiments were carried out using
the transgenic TRE-ECC (clone 1) andCAG-ECC (clone 2)
with a single copy insertion as an example. A time-course
experiment was carried out as shown in Figure 3A and
Supplementary Figure S18A for two weeks. One third of
the cells were harvested at 6 constitutive passages and an-
alyzed by FACS and outward PCR to detect [EGFPcircles].
At passage 1, the [EGFPcircle] genotype in TRE-ECC cells (-
Tet) was mainly found in GFP positive only (GFP+) cells
(Supplementary Figure S19). ΔEGFP and EGFPinvwere
mainly found in mCherry positive only (mCherry+) cells
(Supplementary Figure S19). Over the FACS time-course
the percentage of GFP+ cells declined rapidly from 7.4%
(p.1) to 0.2% (p.4) (Figure 3B). However, the percentage
of mCherry+ cells and co-colored (GFP+mCherry+) cells
were observed at nearly steady levels from p.1-p.6 (Figure
3B). Likewise, in the TRE-ECC (+Tet) cells, the percent-
age of GFP+ cells and high co-colored cells (mCherryhigh+,
GFPlow+), which harbored [EGFPcircles] (Supplementary
Figure S19), declined rapidly from p.1-p.4, close to the di-
lution ratio (i.e. 2.7 ± 1.9). Similar to the experiment -Tet
(Figure 3B), the mCherry+ cells and low co-colored cells
(mCherrylow+, GFPhigh+) were detected at nearly stable lev-
els (Figure 3C, +Tet). Moreover, comparable time-courses
were observed in CAG-ECC experiments (Supplementary
Figure S18B andC).Despite the indicative data fromFACS,
supporting a rapid decrease of cells expressing [EGFPcircles]
over time, when we tested for the stability and presence of
[EGFPcircles] DNA up to day 13 (six passages) by outward
PCR, we found DNA products in all passages. Remarkably,
the detected apparent decrease in [EGFPcircles] from PCR
analysis was slower than the theoretical dilution rate (Fig-
ure 3D and E and Supplementary Figure S18D and E). The
PCR results suggest that [EGFPcircle] DNA can stay rather
stably in HEK cells, as least for the period tested in this
study. However, EGFP expression from [EGFPcircles] is un-
stable and quickly silenced, a pattern similar to EGFP ex-
pression from transiently transfected plasmids. A previous
study has found that transfected plasmids can be asymmet-
rically segregated in dividingmammalian tissue culture cells
(21). Consistent with that, when assaying the median and
mean fluorescence intensity in the remaining small propor-
tion of GFP+ cells (Supplementary Figure S20), we found
that the GFP+ signal intensity increased at later passages.
CRISPR-C can generate eccDNAs of various sizes
We next asked whether CRISPR-C also could generate ec-
cDNA in sizes larger than 2 kb. To address this question, we
generated several pairs of CRISPR gRNAs targeting chro-
mosome 1 (Figure 4A) to test for eccDNA formation in sizes
up to 207 kb. For all examined sites, we confirmed eccDNA
formation by CRISPR-C (Figure 4A–C), confirming that
CRISPR-C can generate eccDNAs in a range of different
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
biosensor. (C) Experimental outline. (D) TRE-ECC plasmid assessment by fluorescence microscopy after Cr1+Cr2 using pUC19 as control (uncut). (E,
upper part) Outline of stable genomic integration of TRE-ECC in HEK293T. (F) Copy-number assessment by Southern blot with EGFP-probe after KpnI
digestion. (E, lower part) Outline for Cr1+Cr2 activation of integrated TRE-ECC. (G) Representative result from FACS analysis of clone 1 in the absence
or presence of tetracycline (Tet). (H) Histograms of fluorescence cell percentages of all 15 isolated TRE-ECC clones after Cr1+Cr2 and FACS analysis. (I)
PCR and Sanger sequencing validation of genotypes on exonuclease-treated DNA, displayed in A, after Cr1+Cr2 for TRE-ECC clone 1 and clone 4. C,
negative CRISPR control; NC, non-template control. (J) Southern blot, probed with EGFP on HEK293T purified and digested DNA from untreated (C,
KpnI) and Cr1+Cr2 treated cells. X = XbaI, H = HindIII.
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Figure 2. Endogenous DNA circularization by CRISPR-C. (A) Chromosome 1 map 2 kb downstream of the CRP locus. gRNA: Cr3, Cr4; diagnostic
oligos: p5 to p8. (B) Experimental outline. (C–E) Gel-images of corresponding PCR products across junctions after testing for (C) DNA deletion, 0.64
kb; wildtype, 1.23 kb), (D) inversion and (E) circular DNA, next to resultant chromatograms from Sanger sequencing. (F) Chromosome 10 map at the
PLAU (UPA) locus. gRNA, Cr5 and Cr6, diagnostic oligos; p9 to p12. (G) PCR and sequencing confirmation of the [UPAcircle exon 4]. (H) Chromosome 19
map at the TRIM28 locus. (I) PCR and sequencing confirmation of the [TRIM28circle exon 1-2]. (J–K) Indel distribution across the junction of [dsCRPcircle]
generated in HEK293T and HMF cells, respectively. For (E), (G) and (I), exonuclease-treated DNA was used as template.
sizes. As controls, we further proved that single double-
strand DNA breaks by CRISPR gene editing did not led
to eccDNA formation (Figure 4A–C) as also observed for
similar control experiments with the ECC biosensor (Sup-
plementary Figures S4 and S6) and the [UPAcircle exon 4] (Fig-
ure 2G).
Generation of ring chromosomes by CRISPR-C
Ring chromosomes are chromosomal alterations found in
humans and have been reported for all chromosomes, which
cause various developmental defects during fetal develop-
ment and are associated to cancers (22). Ring chromosome
18 is found at high frequency in 1 out of 40 000 births
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Figure 3. Stability of eccDNAs generated byCRISPR-C. (A) Outline of time-course experiment. (B) Left, percent fluorescence cells from 1 to 6 cell passages
(1:3 split-ratio) in absence of tetracycline (-Tet); right, corresponding FACS gating images. (C) As B description, cells propagated in +Tet conditions. (D)
Outward PCR analysis of [EGFPcircles] at passage 1 to 6; left, -Tet; right, +Tet. Cr1+Cr2 (1+2), CRISPR gRNAs; C, control – gRNA; ctrl, DNA template
control. (E) Quantification of PCR analysis by Image J, solid lines; theoretical 1/3 dilution rate, dash lines.
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Figure 4. Generation of eccDNAs of various sizes and ring chromosome 18 by CRISPR-C. (A, upper part) Schematic view of distances between targeted
CRISPR gRNAs on chromosome 1 (Cr9 to Cr17) along with diagnostic oligos (p17 to p26) for PCR confirmation of formation of (A, lower part) kb-sized
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(23). Currently, there is no tool for re-modelling ring chro-
mosomes in vitro. We next investigated whether CRISPR-
C can be used to generate ring chromosome 18, Ringchr18.
Two pairs (Cr17+Cr18 and Cr19+Cr20) of CRISPR gR-
NAs were designed to target the p and q aims of chromo-
some 18, respectively. When HEK293T cells were treated
with the designed CRISPR-pairs, we detected both efficient
formation of large DNA deletions, chr1847.4 Mb as well
as Ringchr18:47.4 Mb. Sanger sequencing of amplified PCR
products across the junction validated their structures (Fig-
ure 4D and E). Karyotyping, telomere staining and whole
chromosome 18 painting of HEK293T cells treated with
CRISPR-C further confirmed the appearance of ring18-
like structures with an efficiency of∼2% (2/113 metaphases
analyzed, Figure 4F), whereas no ring18-like structures
were found in untreated cells (0/65 metaphases analyzed,
Supplementary Figure S21). In addition, we observed that
cells with the ring18-like genotype had lower fitness, as the
ring18-like structure was eventually lost from cell culture
when passaged multiple times. This result is not surprising
as ring chromosomes are reported to be unstable (24).
DISCUSSION
We previous demonstrated that CRISPR–Cas9 can be used
for efficient andmultiplexed genetic manipulations (25–27).
Here, we further showed, for the first time, that CRISPR
technology can be used efficiently to form specific eccDNA
sequences in the human genome. Designated CRISPR-C,
eccDNA was formed at all regions tested, if targeted by
CRISPR-pairs on the same chromosome. In detail, the in-
troduction of two double-stranded DNA breaks and subse-
quent DNA repair, mainly driven by blunt end-joining, led
to formation of an eccDNA product and the corresponding
chromosomal DNAdeletion or alternatively to DNA inver-
sion. We demonstrated that CRISPR-C can generate entire
ring chromosomes inside cells and eccDNAs can be gener-
ated in a broad range of sizes from both genic and inter-
genic regions. We provided evidence that DNA circulariza-
tion by CRISPR-C is cell-line independent (Figure 2, Sup-
plementary Figures S13 and S14). Several reports support
that eccDNAs can be transcriptionally active (8,11,16,28–
30).We consolidated previous observations by showing that
cells formed [EGFPcircles], ΔEGFP and EGFPinv genotypes
after CRISPR-C (Figure 1), which led to active expression
of green and/or red fluorescence proteins.
In this study, we confirmed that the ECC biosensor cas-
sette can be used for studying eccDNA biogenesis in hu-
man cells with direct linkage to fluorophore synthesis. The
exogenous ECC biosensor cassette can likely be a useful
marker for deciphering more about the DNA repair ma-
chinery, leading to eccDNA biogenesis. As well, via dual
fluorophore transcription, the ECC biosensor can provide
more insights to the heterogeneity and the mutational spec-
trum when using CRISPR-C. The cassette can either be
transfected as a plasmid into cells or used for viral trans-
duction to generate stable chromosome integration. In fu-
ture experiments, e.g. by cell-dilution down to single cells,
CRISPR-C induced cells could be analysed by targeted se-
quencing or propagated mildly, to assess if mainly homoge-
nous or heterogenous genotypes exist.
Only a few studies have previously looked at eccDNA sta-
bility over time (30,31). Continuous cultures of CRISPR-C
induced stable cells with the ECC biosensor revealed that
the GFP+ cell population diluted out proportionally to
the cell-split ratio after few cell passages (Figure 3B and
C). However, assessed by outward PCR analyses, the pres-
ence of [EGFPcircles] diluted out more slowly (Figure 3E and
Supplementary Figure S18E), suggesting that [EGFPcircles]
could persist in cell populations for much longer time than
two weeks. Furthermore, the more moderate decline in
[EGFPcircles] levels over time advocated for possible repli-
cation and clustering since the GFP+ cell population de-
creased over time while the mean fluorescence intensity per
cells increased significantly (Supplementary Figure S20).
Alternatively, continuousEGFP transcription in slow grow-
ing or quiescence cells could possibly lead to elevated EGFP
levels in a subpopulation of cells. Additional studies will be
needed to elucidate this matter further. In order to gener-
ally assess eccDNA stability in mammalian cells, the ECC
biosensor might be a poor representative as many other un-
known factors might contribute to the stability, such as size
and sequences constitutions (e.g. replication origins, epige-
netics, DNA motifs, repeats, genes, etc.).
Replication of acentric eccDNA in dividing cells can
quickly led to copy-number variations, if segregated asym-
metrically. It remains to be investigated whether the gen-
erated eccDNAs in this study might replicate, which could
explain longer persistence-time and increased intensity in
cells. Previous reports on microscopic visible eccDNAs
(double minutes) showed they can replicate at cell divi-
sion (32–34). Moreover, upon various replicative stresses,
increased eccDNA clustering and micronuclei exclusion
was observed, which correlated with altered cellular traits
(11,29,35).
A link between eccDNA and cellular aging has previ-
ously been described in the eukaryotic cell model of bud-
ding yeast. As for many other eukaryotes, the ribosomal
RNA genes are numerous and highly repetitive in yeast. So-
called [rDNAcircles] (14) or ERCs (36) are frequently pro-
duced and ERC accumulation has been associated to cell
senescence and aging of yeast (36). A potentially similar ac-
cumulation of eccDNAs in human cells could perhaps also
moderate the number of possible cell divisions, causing ag-
ing. EccDNA that encodes a specific gene has also been
shown to improve the growth fitness of yeast (16), confer
drug-resistance for more than 75 days in human cell culture
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
[CRPcircles] and correspondingCRP deletions,CRPchr1. (B andC) Chromatograms of Sanger sequencing across the junction of the [CRPcircle 12 kb] and the
[CRPcircle 207 kb] in both directions and chromatograms below confirming CRP deletions, CRPchr1 12 kband CRPchr1 207 kb. (D) Left, schematic view of
chromosome 18 with annotated Cr18 to Cr21 sites and resultant formation ofRingchr18:47.4 Mb andΔchr1847.4Mb after CRISPR-C and DNA repair. Right,
Sanger sequencing chromatograms confirming expected junctions. (E) Corresponding gel-images of amplified PCR products across junctions associated to
D. Schemes, not drawn to scale. (F) Karyotyping ring18-like structure of chromosome 18 by telomere staining (Telo) and whole chromosome 18 painting
(WCP18) of HEK293T cells treated with CRISPR-C. Blue, DAPI staining of DNA; Red, telomere; Cyan, chromosome 18.
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(30), and to transmit drug-resistance vertically to progeny
of crop weed (37).
In this study, we demonstrated the application of
CRISPR-C in generating eccDNA from different loci, of
different sizes, and even for generation of a circular chromo-
some 18. Our study highlights that future studies of chro-
mosomal abnormalities inmedical genetics, such as translo-
cation, deletion, gene-fusion and ring chromosomes (38)
can now be supplemented by applying CRISPR-C technol-
ogy. This method is especially useful for cancer research as
around half of all tumors carry eccDNAs with oncogenes
(10,11,13). We expect that CRISPR-C will improve our un-
derstanding of the role of endogenous eccDNAs in can-
cer development. The ease of generating ring chromosomes
by CRISPR-C can further provide easier modelling of hu-
man genetic disorders caused by ring chromosomes (22,24).
In addition, the fact that ring chromosomes can be gener-
ated by CRISPR-C, might provide valuable knowledge and
novel concept arts to the design of synthetic chromosomes
(39) and synthetic genomes (40).
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